Score history

Redline Bio Labs score history

Every recorded change to Redline Bio Labs’s overall score since October 20, 2026, with the audit note written at the time. Scores follow our published methodology; affiliate status never affects them.

Score today
4.80/10

Score today

Score changes
16

Score changes

Audit entries
18

Audit entries

Score over time

345Nov 20264.80
Overall score, October 20, 2026 to November 6, 2026. Each dot is a recorded score; the filled dot is today’s.

Every entry newest first

  1. Lowered from4.82to4.80(-0.02)

    Pricing re-checked on 6 November 2026 after the market medians were recalculated with GhostLabz and NextSelf Labs added pricing 7.6 to 7.5.

  2. Raised from4.80to4.82(+0.02)

    Pricing re-checked on 5 November 2026 after the market medians were recalculated with Peptyes added pricing 7.5 to 7.6.

  3. Raised from4.58to4.80(+0.22)

    Lab score recalculated on 31 October 2026 under the uniform rule: five AV Analytics certificates issued on 27 October 2026 (Ipamorelin batch IPA-005, Oxytocin OXY-002, PT-141 PT-002, Sermorelin SER-005, TB-500 TB-006) were added to the listing from the vendor's lab-reports page, each earning 3 base points plus 2 for a laboratory in our directory, with no printed verification key and no purity figure; the laboratory lookup for AV Analytics remains unconfirmed on the vendor's own page. Lab 3.3 to 3.7.

  4. Raised from4.53to4.58(+0.05)

    Core products recomputed on 29 October 2026 (rule A1b): listings added for newly reviewed vendors made NAD+ a core product in place of CJC-1295, so a missing certificate for each now counts at its new weight: lab 3.2 to 3.3.

  5. Raised from4.51to4.53(+0.02)

    Market medians updated after Delix Labs and Ageless Peptides were added pricing 7.4 to 7.5.

  6. Lowered from4.53to4.51(-0.02)

    Pricing recomputed on 26 October 2026: listings added for a newly reviewed vendor (StudzPeptides) moved the market median for the same products: pricing 7.5 to 7.4.

  7. Lowered from4.54to4.53(-0.01)

    Pricing recomputed on 26 October 2026: listings added for a newly reviewed vendor (Lotus Peptide) moved the market median for the same products: pricing 7.6 to 7.5.

  8. Raised from4.53to4.54(+0.01)

    Pricing recomputed on 24 October 2026: listings added for newly reviewed vendors moved the market median for the same products: pricing 7.5 to 7.6.

  9. Lowered from4.54to4.53(-0.01)

    Pricing recomputed on 23 October 2026 under the revised rule E1 (standing offers), which prices a size at the lowest total a buyer can pay without a code under standing prices, so a standing offer that includes a second vial at no extra cost now counts at all the milligrams received, in the vendor's own price and in the market medians for the same products: pricing 7.6 to 7.5.

  10. Raised from4.21to4.54(+0.33)

    Lab score recalculated on 23 October 2026 after the vendor reported that its AV Analytics certificates had become searchable; 12 were confirmed at the laboratory on 23 October 2026. AV Analytics certificates now replace SteriGenix ones for KPV, KLOW, MOTS-c and Semax. The laboratory's record for a Cartalax batch, which the site does not post, reports that identity did not conform to the label claim, so Cartalax scores 0. Lab 2.6 to 3.2. 11 of 47 products now have a certificate confirmed at a directory laboratory, fewer than the half required, so the testing cap still applies; the cap sits above the weighted score, so it does not lower it.

  11. Raised from4.10to4.21(+0.11)

    Lab score recalculated on 22 October 2026 under the published core-product rule (A1b): a missing certificate on one of the 15 most widely carried products still counts fully, while on any other product it now counts at half weight, so a broad catalogue is not penalised as much for its breadth. Lab 2.4 to 2.6.

  12. Lowered from4.20to4.10(-0.10)

    Re-scored on 22 October 2026 under the published rulebook, which now gives one rule for each judgement call and applies it to every vendor: shipping and refunds 7.0 to 6.5.

  13. Re-checked, no change (4.20)

    Re-scored on 22 October 2026 under version 2 of our published rules. No score change. The testing gate is now computed from the certificates instead of set by hand: 7 of 47 products have a certificate from a directory laboratory with the key confirmed at the laboratory, fewer than the half required, so the testing cap applies; the cap sits above the weighted score, so it does not lower it.

  14. Raised from4.14to4.20(+0.06)

    Laboratory directory completed on 22 October 2026: AV Analytics and Analiza Bialek were researched and added under the published lab criteria, so their certificates now receive the recognised-laboratory credit. Lab 2.3 to 2.4.

  15. Raised from3.98to4.14(+0.16)

    Lab deductions independently re-verified from primary sources on 22 October 2026; a deduction that could not be confirmed was removed or reduced. Lab 2.0 to 2.3.

  16. Raised from3.68to3.98(+0.30)

    Re-scored on 22 October 2026 under our published rubric for shipping, pricing, operating history and transparency, applied to every vendor the same day: prices re-read from the vendor's site and matched by milligrams per vial, operating history from the earliest dated evidence of the business, and policies scored item by item. shipping and refunds 5.5 to 7.0, pricing 8.0 to 7.6, operating history 1.0 to 1.8, transparency 4.5 to 5.0.

  17. Lowered from3.95to3.68(-0.27)

    Lab score recalculated on 22 October 2026 under the uniform published rubric applied to every vendor: every listed product was rescored on the same fixed certificate points, with fixed deductions for site statements about testing that the certificates do not bear out and verification codes the issuing laboratory could not find. Lab 2.5 to 2.0.

  18. First publishedat3.95

    lab 2.5 / shipping 5.5 / pricing 8.0 / tenure 1.0 / transparency 4.5. Lab 2.5: six Freedom Diagnostics certificates verified at the laboratory and one BTLabs report are the only independent evidence we could establish; most certificates come from SteriGenix Analytical, which we could not establish as an independent operating laboratory, ten AV Analytics certificates issued on 18 October did not appear in that laboratory's lookup on 20 October, thirteen of 48 matched products carry no report, one retatrutide report shows about half the label claim passed, and the bacteriostatic water certificate prints a batch number that the laboratory's lookup assigns to a separate report for a different client, with the same purity and benzyl alcohol results. Shipping 5.5: same-day UPS Ground dispatch with tracking and a free-shipping threshold, offset by final sales, a preselected paid protection add-on that decides lost-parcel reshipment, and a card surcharge. Pricing 8.0: below the market median on 36 of 48 compared products. Tenure 1.0: the domain is about six months old. Transparency 4.5: a named LLC and a private-mailbox address are published, but no phone number, named people or governing state.

Score changes for every vendor are on the score changes page. Redline Bio Labs may display its current score with the score badge, which updates automatically and has no effect on the score.

Age verification

Are you 18 or older?

Peptide Source Review covers research peptides: substances sold for laboratory and research purposes, not for human consumption. By continuing, you confirm that you are at least 18 years old and that nothing on this site is medical or legal advice.

I am not 18, leave

We use a one-time browser memory (localStorage) so you don’t see this again on this device.